HealthEquity Revenue 2014-2025 | HQY
HealthEquity annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- HealthEquity revenue for the quarter ending July 31, 2025 was $0.326B, a 8.64% increase year-over-year.
- HealthEquity revenue for the twelve months ending July 31, 2025 was $1.269B, a 15.45% increase year-over-year.
- HealthEquity annual revenue for 2025 was $1.2B, a 20.03% increase from 2024.
- HealthEquity annual revenue for 2024 was $1B, a 16% increase from 2023.
- HealthEquity annual revenue for 2023 was $0.862B, a 13.9% increase from 2022.
|
HealthEquity Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $1,200 |
| 2024 | $1,000 |
| 2023 | $862 |
| 2022 | $757 |
| 2021 | $734 |
| 2020 | $532 |
| 2019 | $287 |
| 2018 | $230 |
| 2017 | $178 |
| 2016 | $127 |
| 2015 | $88 |
| 2014 | $62 |
| 2013 | $46 |
|
HealthEquity Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-07-31 | $326 |
| 2025-04-30 | $331 |
| 2025-01-31 | $312 |
| 2024-10-31 | $300 |
| 2024-07-31 | $300 |
| 2024-04-30 | $288 |
| 2024-01-31 | $262 |
| 2023-10-31 | $249 |
| 2023-07-31 | $244 |
| 2023-04-30 | $244 |
| 2023-01-31 | $234 |
| 2022-10-31 | $216 |
| 2022-07-31 | $206 |
| 2022-04-30 | $206 |
| 2022-01-31 | $203 |
| 2021-10-31 | $180 |
| 2021-07-31 | $189 |
| 2021-04-30 | $184 |
| 2021-01-31 | $188 |
| 2020-10-31 | $179 |
| 2020-07-31 | $176 |
| 2020-04-30 | $190 |
| 2020-01-31 | $201 |
| 2019-10-31 | $157 |
| 2019-07-31 | $87 |
| 2019-04-30 | $87 |
| 2019-01-31 | $76 |
| 2018-10-31 | $70 |
| 2018-07-31 | $71 |
| 2018-04-30 | $70 |
| 2018-01-31 | $60 |
| 2017-10-31 | $57 |
| 2017-07-31 | $57 |
| 2017-04-30 | $55 |
| 2017-01-31 | $47 |
| 2016-10-31 | $43 |
| 2016-07-31 | $44 |
| 2016-04-30 | $44 |
| 2016-01-31 | $36 |
| 2015-10-31 | $31 |
| 2015-07-31 | $30 |
| 2015-04-30 | $30 |
| 2015-01-31 | $25 |
| 2014-10-31 | $22 |
| 2014-07-31 | $21 |
| 2014-04-30 | $20 |
| 2014-01-31 | |
| 2013-10-31 | $15 |
| 2013-07-31 | $15 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.768B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.252B | 28.69 |
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| Medpace Holdings (MEDP) | United States | $16.622B | 41.27 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 13.00 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| Revvity (RVTY) | United States | $10.513B | 19.36 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Avantor (AVTR) | United States | $7.759B | 11.85 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Ardent Health (ARDT) | United States | $1.289B | 4.21 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| Embecta (EMBC) | United States | $0.851B | 4.98 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| Nutex Health (NUTX) | United States | $0.595B | 9.01 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.383B | 5.76 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 7.21 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |